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GRASP65, a Protein Involved in the
Stacking of Golgi Cisternae
Francis A. Barr,*³ Magda Puype,² that 40% of cisternae are found in stacks of 2±3 cister-
nae (Preuss et al., 1992), and under some conditions,JoeÈ l Vandekerckhove,² and Graham Warren*
mainly stacked Golgi cisternae can be observed (Ram-*Cell Biology Laboratory
bourg et al., 1993). This conservation of structure impliesImperial Cancer Research Fund
it is linked to some essential function of the Golgi com-London WC2A 3PX
plex. Whatever the cause, it is reasonable to believeUnited Kingdom
that just as the structure of theGolgi is conserved across²Flanders' Institute of Biotechnology
the eukaryotic kingdom, the proteins involved in mediat-Department of Biochemistry
ing the stacking of Golgi cisternae are conserved, too.B-9000 Ghent
Is there any evidence for proteins that might mediateBelgium
the stacking of Golgi cisternae? Intercisternal bridges
have been described in many different species (Amos
and Grimstone, 1968; Franke et al., 1972), implying thatSummary
these structures have a role in holding cisternae to-
gether. More recent electron microscopic studies ofNEM prevents mitotic reassembly of Golgi cisternae
Golgi stacks have revealed that stacking is sensitive tointo stacked structures. The major target of NEM is a
proteases, indicating that it is protein-mediated and that65 kDa protein conserved from yeast to mammals.
regular 8.5 by 11.0 nm projections said to represent theAntibodies to this protein and a recombinant form of
putative proteinaceous intercisternal bridges are visibleit block cisternal stacking in a cell-free system, justi-
on unstacked Golgi cisternae (Cluett and Brown, 1992).fying its designation as a Golgi ReAssembly Stacking
Apart from these observations, little is known about theProtein (GRASP65). One of the two minor targets of
nature of the interactions mediating stacking of cister-NEM is GM130, previously implicated in the docking
nae, and the importance of these interactions for theof transport vesicles and mitotic fragmentation of the
correct functioning of the Golgi complex.Golgi stack. GRASP65 is complexed with GM130 and is
To aid in thecharacterization of interactions importanttightly bound to Golgi membranes, even under mitotic
for maintaining the correct structure and function of theconditions when both are heavily phosphorylated.
Golgi complex,cell-free systems for its disassembly andThese results link vesicle docking, stacking of Golgi
reassembly have been developed (Misteli and Warren,cisternae, and the disruption of both of these interac-
1994; Rabouille et al., 1995a). These systems exploit thetions during mitosis.
observations that during cell division in animal cells, the
stacked cisternal structure of the Golgi complex breaksIntroduction
down into many small vesicles and remnants of cister-
nae that are partitioned between the two daughter cellsThe Golgi complex is characterized by its unique ap-
(Warren, 1993). One of the first alterations in the struc-
pearance, a compact reticulum often found adjacent to
ture of the Golgi complex during mitotic disassembly is
the nucleus during interphase in animal cells at the light
the loss of the stacked cisternal structure, a process
microscope level (Golgi, 1898; Burke et al., 1982). Under
termed unstacking (Misteli and Warren, 1994). It has
the electron microscope, it can be resolved into a series
been shown that the rebuilding of stacked cisternae
of cisternal membranes overlaying one another to form
in this cell-free system is sensitive to the sulphydryl
stacks, which are in turn linked at their edges by tubules
modifying reagent N-ethylmaleimide (NEM) (Rabouille et
to form a ribbon-likestructure (Rambourg and Clermont, al., 1995a). This effect is due to the inactivation of two
1990). Within this structure reside theenzymes responsi-
sets of components. The first are NEM-sensitive factors
ble for the modification of many cellular and secretory
in the cytosol, required for the fusion of the mitotic Golgi
proteins. These enzymes, many of which are glycosyl-
fragments (MGFs) into cisternal structures. These are
transferases, trimming enzymes, sugar transporters, or the NEM-sensitive fusion factor (NSF) and another
enzymes involved in other posttranslational modifica- ATPase termed p97 that is structurally related to NSF
tions, have unique but overlapping distributions (Nilsson (Rabouille et al., 1995b). The other set of components
et al., 1993). The importance of the structure of the are associated with the Golgi membranes, since cytosol
Golgi complex for the localization and correct function is unable to rescue the stacking defect of NEM-treated
of these enzymes is unclear, although it is thought to MGFs even though it does support their fusion into cis-
be important for their correct functioning, since many of ternae (Rabouille et al., 1995a, 1995b).
the enzymes function in an ordered sequence (Farquhar, Similar observations have been made in another sys-
1985). This structure is also conserved throughout the tem (Acharya et al., 1995b) that reconstitutes the forma-
eukaryotic kingdom, from mammals to plants (Mollen- tion of Golgi stacks in permeabilized cells after their
hauer and MorreÂ , 1966; Whaley, 1976), and primitive disruption by the drug ilimaquinone (IQ). When the cells
unicellular eukaryotes (Becker and Melkonian, 1996). are treated with NEM, the IQ-vesiculated Golgi mem-
Even in the yeast S. cerevisiae, which has been reported branes are unable to fuse to form cisternae. This defect
not to have a stacked Golgi, serial reconstructions show can be partially rescued with cytosolic components,
p97, NSF, and SNAPs (Acharya et al., 1995a), although
the cisternae produced in such incubations do not form³To whom correspondence should be addressed.
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proper Golgi stacks; instead, they cluster and fail to
align properly (Acharya et al., 1995a).
In both of the in vitro systems described above, NEM
has similar effects. It causes defects in both the mem-
brane fusion events that generate cisternae and in the
process by which these cisternae form Golgi stacks.
The fact that NEM can prevent stack formation in two
different in vitro systems suggested that this was worthy
of further investigation. Using the cell-free assay for
mitotic disassembly and reassembly of the Golgi (Ra-
bouille et al., 1995a), we set out to identify the proteins
on Golgi membranes that might mediate or establish
the stacking of Golgi cisternae. Candidate proteins in
this system should be NEM-sensitive proteins of Golgi
membranes subject to some form of cell-cycle regula-
tion, possibly by a cycle of direct phosphorylation and
dephosphorylation as the cell enters and exits mitosis.
Results
Figure 1. Reassembly of Golgi Stacks In Vitro Requires NEM- and
BMCC-Sensitive Factors
A Functional Approach to Identify Stacking Proteins Disassembly assays were carried out using mitotic cytosol and rat
It has been shown that when mitotic Golgi fragments liver Golgi membranes pretreated with NEM and quenched with
(MGFs) are treated with NEM and supplemented with DTT. After incubation for 20 minutes at 378C, the membranes were
recovered and either left untreated (control) or treated with NEM oruntreated cytosol, they can fuse in a cell-free system to
BMCC followed by quenching with DTT. Reassembly assays wereform cisternae, but these cisternae do not interact to
then performed for 60 minutes at 378C using control (B), NEM- (C),form Golgi stacks (Rabouille et al., 1995b). It was also
or BMCC- (D) treated membranes and interphase cytosol. Samples
shown that if the starting Golgi membranes were treated of the starting stacked Golgi membrane (A) and the disassembly
with NEM prior to disassembly with mitotic cytosol, they reaction (not shown) were kept on ice for analysis. Samples were
disassembled and reassembled into Golgi stacks to the processed for electron microscopy, and the amount of cisternal
membrane in structures containing either 1, 2, 3, or 4 cisternae wassame extent as control membranes (Rabouille et al.,
quantitated. These values were normalized and the means plotted;1995a). These observations implied that NEM-sensitive
error bars indicate the SEM.components associated with Golgi membranes were
involved in the process by which cisternae form stacks,
they could not be provided by cytosol, and they were present in Golgi stacks was then quantitated. When
stacked Golgi membranes (Figure 1A, RLG) with 2±3not accessible to NEM on the starting Golgi membranes.
We decided to utilize these observations to identify pro- cisternae per stack were treated with NEM and disas-
sembled with mitotic cytosol, a population of largelyteins that might be involved in the establishment or
maintenance of the stacked structure of the Golgi com- single cisternae and tubular networks was generated
(Misteli and Warren, 1994). When supplemented withplex. Our strategy was to first block all accessible sul-
phydryl groups on the starting Golgi membranes with interphase cytosol, these membranes formed stacks of
mainly two cisternae (Figure 1B, R60). If the MGFs wereNEM, then to treat these membranes with mitotic or
interphase cytosols. In the case where mitotic cytosol alkylated with either NEM (Figure 1C, NEM), or BMCC
(Figure 1D, BMCC) prior to addition of interphase cyto-was used, previously inaccessible sulphydryl groups
should be exposed, including those on proteins involved sol, they were unable to form stacks, greater than 80%
of the cisternae being single. The differences observedin stacking of Golgi cisternae, and thus become sub-
strates for NEM. Control reactions performed with in- are not due to changes in the amount of membrane in
reassembled cisternae. Little change in the amount ofterphase cytosolshould not yield the proteins of interest,
since Golgi do not unstack under these conditions (Mis- Golgi membrane found in cisternae was observed when
either control (38% 6 3%), NEM- (34% 6 6%), or BMCC-teli and Warren, 1994). To identify these proteins, we
decided to use the reagent BMCC, which has the same (36% 6 4%) treated membranes were used for the reas-
sembly assay, consistent with previous observationsspecificity as NEM but is modified with a biotin tag
and is thus easy to detect. It was first necessary to (see Table I in Rabouille et al., 1995a). From these results
it was concluded that BMCC, like NEM, is able to modifydemonstrate that this reagent had the same properties
as NEM, in being able to block the stacking of Golgi proteins required for the establishment of stacked Golgi
cisternae.cisternae in the cell-free assay described above.
Golgi membranes were blocked with NEM, then
treated with mitotic cytosol to generate a population of Purification of a Candidate Stacking Protein
The next step was to identify the proteins modified byunstacked short cisternae and vesicles. These mem-
branes were reisolated and either left untreated or alkyl- BMCC on MGFs. Golgi membranes were either left un-
treated or alkylated with NEM prior to incubation withated with NEM or BMCC, followed by incubation with
interphase cytosol to allow regrowth and stacking of either buffer, interphase, or mitotic cytosols. After re-
covery of the membranes, alkylation with BMCC wasGolgi cisternae. The amount of cisternal membrane
A Golgi Stacking Protein
255
detailed in the Experimental Procedures. Briefly, the
method was to extract the doped Golgi membranes with
TX-100 and high salt±containing buffer on ice and to
remove any insoluble material by centrifugation (Figure
2B, lane 1). The cleared lysate was fractionated over a
mono-Q column, and the peak fraction of p65 collected
(Figure 2B, lane 2). This was subsequently gel-filtered
over a Superose 6 column, where the p65 fractionated
as a protein of over 1000 kDa (Figure 2B, lane 3). Up to
this point, both p65 and p130 had cofractionated. The
Superose 6 pool was fractionated over a Biogel-HTP
column, at which step p65 and p130 were separated;
the peaks of both p65 (Figure 2B, lane 4) and p130
(Figure 2B, lane 5) are shown. The pool of p65 was then
applied to a Q-Sepharose column, and the peak fraction
of the eluate is shown (Figure 2B, lane 6). Pure p65 had
an estimated molecular size of 180 kDa by gel filtration
on Superose 6 (not shown). The purification of p65,
based on the ratio of the biotinylated p65 to totalprotein,
was estimated to be 1,200-fold over starting Golgi mem-
branes, and 70,000-fold over rat liver homogenate.
p65 Is a Conserved Protein
The purified 65 kDa protein band was excised fromFigure 2. Proteins Accessible to BMCC on Golgi Membranes
Coomassie blue±stained SDS±PAGE gels and subjected(A) Disassembly reactions were performed with control or NEM pre-
to microsequence analysis. The sequence obtained wastreated rat liver Golgi membranes either in the presence of buffer
(2), interphase (Int), or mitotic (Mit) cytosols. After incubation, the unknown; only a single rat expressed sequence tag
membranes were recovered, biotinylated with BMCC, and then (IMAGE cDNA clone 404929) was found to have homol-
quenched with DTT. Equal amounts of each sample were analyzed ogy with two of the peptide sequences obtained. Nested
by streptavidin overlay to detect biotinylated proteins. Note the
primer pairs were designed for the amplification of themajor biotinylated protein (**) at 65 kDa and the two minor proteins
cDNA for this protein using a RACE protocol. A cDNA(*) at 130 and 160 kDa.
library from rat liver was screened using a fragment of(B) Purification of p65 was performed as described in the methods.
Samples taken at every step of the purification were analyzed by the RACE clones as a probe.The sequences of the entire
SDS±PAGE and silver staining. The position of p65 in lanes 1±4 is coding region and deduced open reading frame are
marked (*). BiogelHTP was used to separate p65 ([*], lane 4) from shown with the microsequenced peptides underlined
p130 ([D], lane 5); p65 was then purified using Q-Sepharose ([**],
(Figure 3A). BLAST searches (Altschul et al., 1990) foundlane 6).
two positive matches similar throughout their lengths in
the yeasts S. cerevisiae (30% identity) and S. pombe
(40% identity), GenBank accession numbers U33057performed and equal aliquots of each sample were ana-
lyzed by streptavidin overlay to detect the BMCC-modi- and Z69239, respectively. Partial sequences present in
the human and mouse EST databases were also found.fied proteins. In the absence of any NEM pretreatment
of the starting Golgi membranes, many proteins were None of these sequences has any function ascribed to
it or has any significant homology to any gene of knownlabeled by BMCC when either interphase (Figure 2A,
lane 1) or mitotic (Figure 2A, lane 2) cytosols were used. function. Comparison of the cloned rat sequence with
the yeast sequences and a partial mouse EST revealsIf the starting Golgi membranes were blocked with NEM,
a completely different result was obtained. When buffer a highly conserved region of 100 amino acids (50%±60%
similarity, 40% identity) containing a single conservedalone was used for the incubation, no proteins were
found to be labeled by BMCC (Figure 2A, lane 3). A cysteine residue corresponding to position 191 in the
rat sequence (Figure 3B). This cysteine residue mightsingle weakly labeled band was seen at 150 kDa when
Golgi membranes were treated with interphase cytosol explain the sensitivity of the protein to the sulphydryl
modifying agents NEM and BMCC. Inspection of the(Figure 2A, lane 4). In contrast, when mitotic cytosol was
used, a major band of 65 kDa and two less intense bands sequence reveals no membrane-spanning domain, but
a glycine was present at position two in a context thatat 130 kDa and 160 kDa were seen (Figure 2A, lane 5).
These proteins specifically labeled by BMCC on MGFs means that itwould be a good candidate for N-myristoy-
lation (Johnson et al., 1994), thus providing a way towere thus candidates for the NEM-sensitive Golgi stack-
ing proteins. anchor p65 directly to membranes.
Since stacked Golgi membranes are present in allFocusing on p65, it was decided to scale up the pro-
duction of biotinylated MGFs, then to add these to an nucleated mammalian cells, it was important to show
that this gene was expressed in all tissues. Northernexcess of untreated Golgi membranes. It was assumed
that the nonbiotinylated and biotinylated forms of the blot analysis of a variety of rat tissues revealed that a
2.5 kb message, corresponding exactly to the size of theproteins would behave in the same way, allowing them
to be followed through the subsequent purification as clone identified, is present in all of the tissues examined
Cell
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Figure 4. p65 Is a Tightly Associated Peripheral Golgi Membrane
Protein
(A) A 10 mg aliquot of RLG membranes was analyzed by Western
blotting with an antibody (FBA21.1) raised to amino acids 220±234
of the p65 sequence. The antibody was used either with (1) or
without (2) preincubation with the peptide against which it was
raised. Equal amounts of the homogenate, cytosol, and Golgi frac-
tions of a rat liver Golgi purification were analyzed by Western blot-
ting with anti-p65 antibody.
(B) Golgi membranes were treated as follows: 10 mg were incubated
in either buffer, 10.0 mg/ml trypsin, 10.0 mg/ml chymotrypsin
(ChymoT), or 1.0 mg/ml proteinase K (prot-K) for 15 minutes on ice;
25 mg were incubated on ice for 60 minutes in a buffer containing
either 10 mM EDTA, 1 M KCl, or 100 mM sodium carbonate (pH 11).
The membranes were recovered and equal aliquots analyzed by
Western blotting with antibodies to p65, GM130, or Mann II; 25 mg
of Golgi membranes were subjected to Triton-X 114 partitioning,
and equal aliquots of the aqueous (Aq), detergent phases (D), or
insoluble pellet (P) analyzed by Western blotting with antibodies to
p65, GM130, or Mann II.
(C) In vitro transcription-translation reactions with [3H]myristic acid
were performed from a control plasmid (2) or a plasmid with the
p65 clone (1) and analyzed by SDS±PAGE and fluorography.
(Figure 3C). Interestingly, an additional second message
of 1.5 kb is present in testis (Figure 3C).
To further verify that this was the correct clone for
the biotinylated 65 kDa protein, in vitro transcription-
translation was performed. When analyzed by SDS±Figure 3. The Sequence of p65 Shows It to Be a Conserved Protein
PAGE and autoradiography, a major band at 65 kDa (*)(A) Nested 59 and 39 RACE reactions with gene-specific primers
was visible (Figure 3D, [1]) that was absent from thedesigned from the IMAGE rat cDNA clone404929 yielded two groups
of overlapping clones. A rat liver cDNA library in lgt11 was screened control reaction (Figure 3D, [2]). These data support the
with a probe derived from these RACE products. The sequence of view that this clone corresponds to p65.
the cDNA obtained is shown, together with the predicted protein
sequence. Peptides from the microsequencing of p65 are under-
p65 Is an N-Myristoylated Peripheral Golgilined.
Membrane Protein(B) Alignment of the conserved region of rat p65 with the S. cerevis-
To investigate the properties of p65, specific antibodiesiae and S. pombe homologs, and the partial mouse EST W75513.
Identical (*) and conserved (.) residues are marked. The conserved were raisedagainst amino acids 214±228 of the deduced
cysteine residue is marked ( Ã ). sequence. These recognized a protein of 65 kDa in Golgi
(C) A Northern blot with 2 mg of poly(A)1 RNA per lane from each membranes (Figure 4A, [2] peptide), but not after prein-
of the indicated tissues was screened with a random-primed probe
cubation with the peptide (Figure 4A, [1] peptide). Thederived from a SmaI fragment of the p65 clone.
65 kDa protein recognized by these antibodies was en-(D) In vitro transcription/translation reactions with [35S]methionine
riched in Golgi membranes (Figure 4A, Golgi) comparedwere performed from a control plasmid (2) or a plasmid with the
p65 clone (1). The reactions were analyzed by SDS±PAGE and to rat liver homogenate (Figure 4A, homogenate) and
autoradiography. The 65 kDa translation product is marked (*). was absent from the cytosolic fraction (Figure 4A, cy-
tosol).
The orientation of p65 in Golgi membranes was probed
using proteases, under conditions previously shown to
A Golgi Stacking Protein
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result in the digestion of cytoplasmically oriented pro-
teins and unstacking of Golgi cisternae (Cluett and
Brown, 1992). As controls, GM130, a cytoplasmically
oriented peripheral membrane protein, and mannosi-
dase II (Mann II), a lumenal protein, were used. Trypsin,
chymotrypsin, or proteinase K treatment (Figure 4B) re-
sulted in the total digestion of both p65 and GM130,
whereas Mann II (Figure 4B) was unchanged. This obser-
vation shows that p65, like GM130, is oriented toward
the cytoplasm. To find out how tightly p65 is associated
with Golgi membranes, these were mock treated and
washed with 10 mM EDTA, 1 M KCl, or 100 mM sodium
carbonate (pH 11.0), the membranes pelleted, and the
supernatants and pellets analyzed by Western blotting
with specific antibodies. When an integral membrane
protein such as Mann II was examined (Figure 4B), it
was found in the pellet fraction under all conditions. A
tightly associated peripheral membrane protein such as
GM130 was found in the pellet, except when 100 mM
sodium carbonate was used (Figure 4B). Under thesame
conditions, p65 was found to behave exactly as did
GM130 (Figure 4B), implying that it is a tightly associated
peripheral membrane protein. To confirm this observa-
tion, phase partitioning of Golgi membranes with TX-114
was performed, and equal aliquots of the aqueous
phase, detergent phase, and insoluble pellet were ana-
lyzed by Western blotting. Again, it was found that p65
and GM130 behaved identically, both partitioning into
the aqueous phase, while Mann II partitioned between
both aqueous and detergent phases (Figure 4B). From
these data, it was concluded that p65 is a tightly associ-
ated peripheral protein of Golgi membranes.
How then does p65 associate with Golgi membranes?
Unlike GM130, which has no transmembrane domain or
known lipid modifications that might explain its interac-
tion with the membrane, p65 has a potential N-myristoy-
lation site. To test if this site is actually used, the p65
Figure 5. Localization of p65 to the Golgi by Immunofluorescenceclone was in vitro-translated in the presence of [3H]my-
(A±F) NRK cells were processed for double-label immunofluores-ristic acid that will be transferred by N-myristoyltransfer-
cence using ([A], [C], and [E]) p65 polyclonal antibodies, and mono-ase to the protein if the glycine at position two is a
clonal antibodies to (B) p115, (D) Mann II, or (F) GalT.
substrate for modification. When analyzed by SDS± (G±J) Hela cells transfected with rat p65 were processed for double-
PAGE and autoradiography, a single band at 65 kDa label immunofluorescence microscopy using ([G] and [I]) p65 poly-
clonal antibodies, and monoclonal antibodies to (H) p115, or (J)was visible (Figure 4C, [1]) that was absent from the
GalT.control reaction (Figure 4C, [2]). This result shows that
p65 is a substrate for N-myristoylation and might associ-
ate with membranes via its N-terminal myristic acid
II (Figure 5D), or GalT (Figure 5F) revealed a considerablemoiety.
overlap with these three Golgi markers. The degree of
overlap was less with the TGN marker than the cis-
and medial/trans-Golgi markers, implying that p65 isLocalization of p65 to the Golgi Complex
To confirm that p65 is a Golgi protein, methanol-fixed localized more to the stacked regions of the Golgi
complex.NRK cells were stained with rabbit polyclonal antibodies
to p65 and monoclonal antibodies to either p115, a Transient transfection studies on Hela cells were car-
ried out to provide further evidence that p65 is a proteinmarker of cis-Golgi, Mann II, a marker for medial/trans-
Golgi, or b-1,4-galactosyltransferase (GalT) a marker for specifically present on Golgi membranes. Rat p65 was
transfected into Hela cells, and after 24 hours, the cellsthe trans-Golgi and trans-Golgi network (TGN). It was
not possible to perform double labeling with the poly- were processed for immunofluorescence. The antibody
used to detect p65 was made against a region of theclonal p65 and monoclonal GM130 antibodies, since
the former only works in methanol- and the latter in protein not conserved from rat to human, and thus only
recognized the transfected rat p65. At low levels of ex-paraformaldehyde-fixed cells. Labeling for p65 revealed
a perinuclear, reticular staining pattern (Figures 5A, 5C, pression, p65 was found to target only to the Golgi
complex (Figure 5G and 5I), as assessed by comparisonand 5E) characteristic of the Golgi complex in these
cells. Comparison of this with p115 (Figure 5B), Mann with the staining patterns of either p115 (Figure 5H) or
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6A, GM130), both absent in the control lane (Figure 6A,
Con). These bands corresponded exactly with the 65
and 130 kDa biotinylated proteins found in total biotinyl-
ated MGFs. Thus, p65 is the major and GM130 one of
the two minor proteins accessible to BMCC on MGFs.
The IPs also reveal that biotinylated p65 (Figure 6A, P65)
and GM130 (Figure 6A, GM130) co-IP from MGFs. These
data suggested that p65 and GM130 form a complex in
Golgi membranes under mitotic conditions.
To find out if p65 and GM130 interact under interphase
Figure 6. p65 and GM130 Form a Tight Complex on Golgi Mem- as well as mitotic conditions, IPs from Golgi membrane
branes extracts were performed using polyclonal antibodies to
(A) Biotinylated MGFs (bMGFs), solubilized in IP buffer, were sub- p65 and GM130. Comparison of total Golgi membrane
jected to IP with either GM130 (GM130 IP) or p65 (P65 IP) polyclonal
extract (Figure 6B, RLG) and the immunoprecipitatedantibodies, or the corresponding preimmune serum (Con IP). Ali-
material by Western blotting with a monoclonal antibodyquots of the total and bound fractions were analyzed by streptavidin
to GM130, revealed that GM130 co-IPs with p65 (Figureoverlay.
(B) RLG membranes, solubilized in IP buffer, were subjected to IP 6B, P65). The GM130 band is absent from the control
with either GM130 (GM130 IP) or p65 (P65 IP) polyclonal antibodies, (Figure 6B, Con) but present in the GM130 IP (Figure
or the corresponding preimmune serum (Con IP). Aliquots of the 6B, GM130). These data suggest that p65 and GM130
total and bound fractions were analyzed by Western blotting with
tightly interact in untreated Golgi membranes. The recip-a monoclonal antibody to GM130. Note the cross-reactivity of the
rocal blotting could not be performed since cross-reac-secondary antibody with unreduced antibody chains (P65 IP).
tivity with the secondary antibodies masked any p65(C) RLG membranes labeled with [g-32P]ATP under mitotic (left panel)
or interphase (right panel) conditions were solubilized in IP buffer signal in the IPs (data not shown). Interaction of p65
and subjected to IP with either GM130 (GM130 IP) or p65 (P65 IP) and GM130 from Golgi membrane extracts has been
polyclonal antibodies, or the corresponding preimmune serum (Con
demonstrated under both mitotic and nonmitotic condi-IP). Aliquots of the total and bound fractions were analyzed by
tions, implying that they form a stable complex.SDS±PAGE and autoradiography.
GalT (Figure 5J). It was not possible to use the antibody Mitotic Phosphorylation of p65
to Mann II in these experiments, since it is specific for One of the criteria in our original definition of candidate
the rat protein. Analysis of p65 distribution by electron
stacking proteins was that they should be subject to
microscopy has been hampered by the low levels of
some form of cell-cycle regulation. The most likely form
antibody labeling caused by sensitivity to the aldehyde
of regulation is direct phosphorylation during mitosis.To
fixation necessary in sample preparation.
investigate this, standard disassembly reactions were
These findings indicate that p65 is most likely to be
performed with either interphase or mitotic cytosols in
found on the cis and medial regions of the Golgi, rather
the presence of [g-32P]ATP to label any phosphorylated
than the more reticular TGN (Nilsson et al., 1993), consis-
proteins. The membranes were recoveredand subjectedtent with its putative role in the establishment or mainte-
to IP with p65 or GM130 antibodies. IPs from mitoticnance of stacked Golgi cisternae.
incubations with p65 (Figure 6C, P65) or GM130 (Figure
6C, GM130) antibodies brought down a major phosphor-p65 Exists in a Complex with GM130
ylated band at 65 kDa and a minor band of 130 kDa, bothon Golgi Membranes
absent from the control (Figure 6C, Con), confirming thatTo prove that p65 was one of the proteins specifically
p65 and GM130 are phosphorylated and still interactbiotinylated in the MGFs, immunoprecipitations (IP) us-
under these conditions. IPs from interphase incubationsing p65 antibodies were performed from these BMCC-
with p65 (Figure 6C, P65) or GM130 (Figure 6C, GM130)treated membranes. When analyzed by streptavidin
antibodies brought down a minor phosphorylated bandoverlay, a 65 kDaprotein was visible in the p65 IP (Figure
at 65 kDa absent from the control (Figure 6C, Con),6A, P65) that was absent in the control lane (Figure
indicating that p65 and GM130 are only very weakly6A, Con). In addition, the 130 kDa biotinylated protein
phosphorylated under these conditions. Comparison ofpresent on MGFs was found to co-IP with p65 (Figure
the total phosphorylation pattern of MGFs (Figure 6C,6A, P65). During the purification of p65, it was noted
MGF) with the p65 (Figure 6C, P65) and GM130 (Figurethat the p130 copurified up to the biogel-HTP step and
6C, GM130) IPs revealed that these are among the majorwas only then separated from p65 (Figure 2B, lanes 4
phosphoproteins. These observations support the viewand 5). Microsequencing of the semipurified p130
that p65, as one of the major mitotic phosphoproteins,yielded two major peptides, FLAVSQNPADVPAPV and
plays a key role in the structural changes seen in theAELQTALAHTQQAAR. These are perfect matches for
Golgi during mitosis.rat GM130, a known component of a putative Golgi ma-
trix also involved in the establishment of vesicle docking
interactions (Nakamura et al., 1995, 1997). To test for
p65 Is Involved in Golgi Stackingan interaction between p65 and GM130, IPs with anti-
To provide direct evidence that p65 is involved in thebodies to GM130 were performed from biotinylated
mechanism by which Golgi cisternae come together toMGFs. When analyzed by streptavidin overlay, proteins
of 130 kDa and 65 kDa were visible in GM130 IPs (Figure form ordered stacks, we decided to test the effects of
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anti-p65 antibody blocked with the peptide against
which it was raised, or the recombinant His-tagged p65,
followed by incubation with interphase cytosol to allow
the regrowth and stacking of cisternae. Reassembly of
control MGFs (Figure 7A, R60) gave rise to Golgi stacks
with 2±3 cisternae per stack, as expected. When the
MGFs were preincubated with the anti-p65 antibody or
an excess of the recombinant p65 protein, a different
result was obtained. In these cases (Figure 7B, anti-
p65; Figure 7D, His-P65), Golgi stacks were not formed;
rather, a population of single cisternaeand vesicleswere
observed similar to those seen with NEM or BMCC treat-
ment. When the anti-p65 antibody was preincubated
with the peptide against which it was raised, reassembly
occurred as in the control incubation, stacksof 2±3 Golgi
cisternae being generated (Figure 7C, anti-p65). These
differences are not due to changes in the amount of
membrane in reassembled cisternae, as this was not
significantly changed when either control (34% 6 6%),
anti-p65 (31% 6 2%), anti-p65 plus peptide (36% 6
5%), or His-tagged p65 (29% 6 2%) treated membranes
were used for the reassembly assay.
From these results, we concluded that recombinant
p65 and antibodies to p65 act to specifically block the
formation of Golgi stacks but not the formation of cister-
nae in the cell-free system for Golgi reassembly. This
provides strong evidence that p65 is a key component
of the mechanism giving rise to the stacked cisternal
structure of the Golgi complex.
Discussion
We have exploited the NEM sensitivity of the cell-free
system for disassembly and reassembly of the Golgi
complex to identify proteins involved in establishing its
stacked cisternal structure.Using this system, we identi-
fied one major and one minor protein. The major protein
was p65, and the minor protein was GM130, a vesicle
docking receptor and component of a putative GolgiFigure 7. Stacking of Golgi Cisternae Is Blocked by Antibodies to
matrix (Nakamura et al., 1995, 1997). Several lines ofp65 and a Recombinant Form of p65
evidence point to the involvement of p65 in Golgi stack-Disassembly assays were carried out using mitotic cytosol and rat
ing: (1) it is a tightly bound peripheral protein that isliver Golgi membranes for 30 minutes at 378C. The membranes were
recovered and treated for 15 minutes on ice with either buffer (A), restricted to Golgi membranes; (2) it is modified in a cell
2.0 mg of affinity purified anti-p65 antibody (B), the same antibody cycle±regulated manner, and during mitosis it is a major,
that had been preincubated with 2.0 mg of the peptide against which if not the major, phosphorylated Golgi protein; (3) when
it was raised (C), or 1.0 mg of recombinant His-tagged p65 (D).
added to the Golgi reassembly assay, antibodies to theReassembly assays were then performed for 60 minutes using these
native protein blocked the stacking but not the regrowthmembranes and interphase cytosol at 378C. Samples were pro-
of cisternae; (4) similar results were obtained adding ancessed for electron microscopy, and the amount of cisternal mem-
brane in structures containing either 1, 2, 3, or 4 cisternae quanti- excess of a soluble recombinant form of p65 lacking
tated. These values were normalized and the means plotted; error the N-terminal myristic acid; and (5) p65 is conserved
bars indicate the SEM. Examples of the images analyzed are shown from yeast to mammals. These results justify the desig-
on the right; magnification bar 5 0.2 mm.
nation of p65 as a Golgi ReAssembly Stacking Protein
(GRASP65).
p65-specific reagents in the cell-free system for Golgi
reassembly. For this purpose, we chose to use an anti-
A Protein Complex Involved in Golgi Stackingbody to p65 (FBA21.1) that recognizes the protein under
GRASP65 interacts with GM130 to form a stable com-native conditions, for example in native IPs (Figure 6B,
plex that is not disrupted under either interphase orP65), and a recombinant His-tagged form of the protein
mitotic conditions. It is known that GM130 in detergentpurified from bacteria.
extracts of Golgi membranes, like GRASP65, gel-filtersDisassembly of stacked Golgi membranes was per-
at about 1.2 MDa, implying that it is in a large oligomericformed with mitotic cytosol to give rise to a population
structure (Nakamura et al., 1995). These observationsof unstacked short cisternae and vesicles. These mem-
branes were treated with either anti-p65 antibody, the indicate that GRASP65 and GM130 are part of a large
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complex containing other Golgi proteins. One protein in addition to its myristic acid anchor, or it interacts with
a protein that has one.that interacts with the GM130 component of this com-
plex is already known (Nakamura et al., 1997). It is p115,
a protein associated with early events in vesicle docking Regulation of Golgi Structure by GRASP65
prior to the action of NSF (Sapperstein et al., 1996). The process of stacking can be viewed as a specialized
GM130 binds to p115 in a cell cycle±regulated manner form of docking event, that of one cisterna with another.
and is thought to be involved in the disruption of the This docking event, unlike that which occurs when a
Golgi in mitosis, when continued vesicle budding in the vesicle interacts with its target membrane, would not
absence of fusion is thought to lead to its fragmentation result in fusion of the two membranes but rather in a
and subsequently, in the membrane fusion reactions stable interaction. This interaction could be regulated
required for the regrowth of cisternae during Golgi reas- by phosphorylation, since GRASP65, like GM130, is a
sembly (Nakamura et al., 1997). These observations do substrate for mitotically active protein kinases. Thus,
not exclude a role for GM130 with GRASP65 in stacking. phosphorylation may regulate two different but possibly
While p115 (Sapperstein et al.,1995) and GRASP65 have linked functions associated with the GRASP65±GM130
homologs in yeast, no homolog of GM130 has yet been complex: (1) vesicle docking via p115±GM130 interac-
described. This might indicate that vesicle docking and tions, and (2) stacking via interactions of GRASP65 with
cisternal stacking are regulated differently in yeast and as yet unknown proteins. It is not yet clear if the complex
mammals but share some of the same components, containing GRASP65 and GM130 is required for the es-
such as p115/Uso1p and GRASP65, respectively. tablishment of the interactions occurring between stacked
cisternae, in their maintenance, or in both of these pro-
cesses. A parallel could be drawn with the nerve termi-
NEM Sensitivity of the GRASP65±GM130 Complex nus, where the vesicle docking event with the plasma
There are two possibilities that could explain how the membrane found in all cells has been modified by the
modification of the GRASP65±GM130 complex in MGFs presence of accessory subunits, exemplified by the syn-
by NEM or BMCC might block stacking in the cell-free aptotagmin family of proteins, to allow regulation by
assay. One is that modification by these reagents inacti- calcium. Synaptotagmins bind to components of the
vates an enzymatic activity required for Golgi stack for- exocytic machinery, the SNAREs, and exert an inhibitory
mation, in a similar fashion to the NEM inhibition of effect on membrane fusion (Schiavoet al., 1995). Binding
vesicle fusion where NSF is the target (Block et al., 1988). of calcium to synaptotagmin triggers the release of this
The other is steric hindrance due to modification of a inhibitory action and allows the docked synaptic vesicle
cysteine residue in some key region of the target protein to fuse with the presynaptic membrane. Thus, GRASP65,
required for interaction with another protein. An example possibly in conjunction with GM130 and p115, could act
of this is in the NEM inhibition of n-sec1 binding to to modulate docking interactions between Golgi cister-
syntaxin 1A (Meffert et al., 1996). Given that neither nae, with phosphorylation rather than calcium binding
GRASP65 nor GM130 have homology to any known en- being the regulatory trigger. During mitosis, phosphory-
zyme, it is more likely that NEM and BMCC are acting lation of GRASP65 and GM130 could lead to disruption
by steric hindrance, preventing the reassociation of of these interactions, allowing the unstacking and sub-
the GRASP65±GM130 complex with other proteins, or sequent fragmentation of the Golgi complex.
changes in its oligomeric state after mitosis.
Experimental Procedures
Association of the GRASP65±GM130 Complex Materials
with Golgi Membranes Chemicals were supplied by the Sigma Chemical Co. (St. Louis, MO)
and BDH Ltd. (Poole, UK) unless otherwise indicated. Chromatog-GRASP65 and GM130, although not integral membrane
raphy resins were from Pharmacia Biotech, except Biogel-HTP sup-proteins, are tightly associated with the membrane, be-
plied by Bio-rad Laboratories. NEM 125 mM (503) stock in DMSO,ing resistant to stripping with 1 M KCl but removed with
and 1-Biotinamido-4-[49-(maleimidoethyl-cyclohexane)carboxyamido]
pH 11 sodium carbonate. How then, do they associate butane (BMCC) 17 mM (503) stock in DMSO (Pierce and Warriner
with Golgi membranes? GM130 lacks any hydrophobic UK Ltd.), and DTT (Boehringer Mannheim, UK) 250 mM (503) stock
segments or known covalent modifications, such as in water, were stored at 2208C. Antibodies were as follows: NN5-1
rabbit polyclonal and monoclonal 2C10 to GM130; monoclonalfatty-acylation, that could mediate its interaction with
53FC3 to Mann II; monoclonal GTL2 to GalT; and monoclonal 4H1membranes (Nakamura et al., 1995). Since GM130 and
to p115.GRASP65 are tightly associated in a complex on the
surface of Golgi membranes that is not disrupted in
Cell-Free Incubationsmitosis, it is possible that one of the functions of
Disassembly and reassembly assays were carried out using Hela
GRASP65 is to target GM130 to Golgi membranes. The N cytosols and purified rat liver Golgi membranes (Rabouille et al.,
terminus of GRASP65 is N-myristoylated, a modification 1995a). Golgi membranes were treated on ice with 2.5 mM NEM or
0.34 mM BMCC for 15 minutes followed by quenching with 5 mMknown to be sufficient for the targeting of some proteins
DTT for 10 minutes. After incubations with cytosol, Golgi membranesto membranes (Johnson et al., 1994). Although N-myris-
were recovered by centrifugation through a 1 ml cushion of 0.5 Mtoylation can form an essential component of a Golgi
sucrose in 100 mM potassium phosphate (pH 6.7) at 55 Krpm fortargeting signal, for example in epithelial nitric oxide
20 minutes at 48C in the TLS55 rotor.
synthase (Liu et al., 1996), alone it is not specific for To prepare 32P-labeled Golgi membranes, standard 50 ml disas-
Golgi membranes (Johnson et al., 1994). This implies sembly reactions were performed using interphase or mitotic cyto-
sols with the addition of 100 mCi of [g-32P]ATP (160 mCi/ml, ICNthat either GRASP65 possesses a Golgi targeting signal
A Golgi Stacking Protein
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Pharmaceuticals Inc.). The 32P-labeled membranes were recovered collecting 1 ml fractions. Peak fractions of p65 were pooled (2 ml)
and subjected to chloroform-methanol precipitation to remove theas above for further analysis.
TX-100. The pellet was solubilized in 200 ml of sample buffer, sub-
jected to SDS±PAGE, and the band corresponding to 50±75 mg p65Electron Microscopy and Stereology
(BSA as standard) excised from the Coomassie-stained gel. TheStandard techniques for the fixation, processing, sectioning, and
peak fractions of p130 from the Biogel-HTP column were subjectedstaining of samples wereused (Misteli and Warren, 1994). Stereolog-
to methanol-chloroform precipitation and fractionated by SDS±ical definitions and methods were as defined previously (Misteli and
PAGE as for p65, and the well-resolved band in this region wasWarren, 1994) and were briefly as follows. Cisternae were membrane
excised.profiles with a length more than four times their width, which was
not greater than 80 nm. Stacks were two or more cisternal profiles
separated by a gap of no more than 15 nm, overlapping by greater Protein Microsequencing
than half their length. Stacks were subdivided into categories based Bands excised from multiple gels were combined and reconcen-
on the number of cisternae in the stack. The relative proportion of trated in a secondary gel (Gevaert et al., 1996). The concentrated
each category of membrane was determined by counting the num- protein was digested in-gel with 1.0 mg of trypsin in 20 ml of 0.1 M
ber of intersections of each membrane structure with a 4 mm line Tris±HCl (pH 8.6), 1 mM CaCl2 for 8 hours at 378C. After digestion,
grid. From these values, the relative amount of stacked cisternal the supernatant was removed and placed in a clean tube. The gel
membrane and the distribution of this membrane in stacks of n slice was extracted for 20 minutes with 60% acetonitrile in 0.1%
cisternae were calculated. trifluoroacetic acid (TFA), combined with the supernatant, and dried
down. This residue was dissolved in 200 ml of 0.1% TFA, injected
SDS±PAGE and Western Blotting on a C-18 RP-HPLC column (2.1 mm 3 250 mm; Vydac Separations
Protein samples were solubilized in SDS±PAGE sample buffer, Group, Hesperia, CA) that was eluted with a linear gradient of aceto-
boiled for 3 minutes, and analyzed on SDS±polyacrylamide gels. nitrile in 0.1% TFA. The eluate was split: 80% into a UV absorbance
Western blotting was performed using a semidry blotter on nitrocel- detector and 20% into a Fisons/VG Platform (Manchester, UK) mass
lulose. Blocking and antibody incubations were performed in PBS spectrometer. Peptides absorbing at 214 nm were collected, and
plus 10% (w/v) low-fat skim-milk powder. All secondary antibodies those corresponding to single peptide masses were selected for
or streptavidin were HRP conjugates (Tago, Buckingham, UK) de- automated Edman degradation.
tected using ECL (Amersham Life Science, UK).
CloningPurification of p65
Nested primers designed from the rat EST sequence were: FM1,Golgi membranes were prepared (Nakamura et al., 1995) from the
GCTAGGGGCAAGCAGCGAGCACGTGTGGC; FM3, GCTGGATGTGlivers of 48 male Sprague-Dawley rats; when pooled, these yielded
GAGCCCTCTTCACCCGCTG; FM2, GCCAAGGTGTGGGGCACCAA70 mg of membrane protein, at 4.7 mg/ml, purified 130-fold over
GAGGAAAGGC; and FM6, GCATTAGGTTGTGGGGTCTTAGCTGGAthe homogenate as judged by the specific activity of GalT. All of the
GTGCC. Nested RACE reactions with a rat liver cDNA pool as thefollowing stepswere performed at 48C.The sucroseconcentration of
target and pfu polymerase (Stratagene, UK) were performed withthe pooled Golgi membranes was adjusted to 0.25 M by addition
adaptor primers AP1 and AP2from the Marathon cDNA kit (Clontech,of PA (100 mM potassium phosphate buffer [pH 6.7]) to give 34 ml,
CA) with either primers FM1 and FM3, or FM2 and FM6 for 39 andfollowed by the addition of 11.3 ml of 4 M KCl. After 10 minutes on
59 RACE, respectively. Overlapping RACE clones were fused at aice, the membranes were pelleted by centrifugation at 10 Krpm for
unique KpnI site to generate a full-length cDNA in the EcoRV site30 minutes at 48C in the Beckman SW28 rotor. The supernatant
of pBluescript II (pBSII, Stratagene, UK). To confirm that the RACEwas discarded and the membranes resuspended in 10 ml of PA
clones were correct, a 1.5 kb SmaI fragment from the predictedcontaining 0.25 M sucrose. Biotinylated MGFs prepared from 1.0
open reading frame was used to screen a rat liver cDNA library inmg of Golgi membranes were mixed with the washed membranes
lgt11 (RL5001b, Clontech, CA). Screening of 1.5 million plaques atand pelleted as above, and then the pellet was resuspended in 10 ml
medium stringency resulted in the identification of eight positiveof PA containing 1% (w/v) TX-100, 1 M KCl, and protease inhibitors (2
clones. The inserts from these phage were subcloned into the EcoRI
mg/ml aprotinin, 100 mM chymostatin, 10 mM leupeptin, 1 mM pep-
site of pBSII for restriction mapping and sequencing.statin A, 0.5 mM 1,10-phenanthroline, 0.25 mM PMSF, 1 mM EDTA).
After 10 minutes, the detergent extract was diluted to 100 ml with
PA containing 1% (w/v) TX-100 and centrifuged at 2000 g for 10 Northern Blotting
minutes to pellet any insoluble material. The cleared extract (50 ml A multiple rat tissue Northern blot (Clontech, CA) with approximately
aliquots) was loaded on a mono-Q HR5/5 column equilibrated with 2.0 mg of poly(A)1 RNA from the tissues indicated in the appropriate
Q100 (25 mM Tris±HCl [pH 7.4], 100 mM KCl, 1% [w/v] TX-100). figure legend, was hybridized with a random-primed 1.5 kb SmaI
After washing with 10 ml of Q100, the column was eluted with a 40 fragment of the p65 clone. After hybridization, the filter was washed
ml linear gradient of Q100 to Q1000 (25 mM Tris±HCl [pH 7.4], 1000 at medium stringency then exposed to film.
mM KCl, 1% [w/v] TX-100) collecting 1 ml fractions. Aliquots of each
fraction were analyzed by streptavidin overlay to detect biotinylated
In Vitro Transcription-Translationproteins. Fractions from 300±350 mM KCl containing the peak of
In vitro transcription-translation reactions (Promega) of 50 ml werep65 and p130 were pooled, then loaded (1 ml aliquots) on a Superose
performed with the T7 polymerase for 2 hours at 308C using 0.5 mg6 HR10/30 column equilibrated with Q1000, and 1 ml fractions were
of plasmid DNA and methionine minus amino acid mix plus 4 mlthen collected. Peak fractions of p65 and p130, gel-filtering at an
of [35S]L-methionine (typically 1400 Ci/mmol and 11 mCi/ml, ICNapproximate molecular weight of 1.2 MDa, were pooled (8 ml), di-
Pharmaceuticals Inc.) or total amino acid mix plus 0.5 ml of [3H]myris-
luted to 40 ml of Q0 (25 mM Tris±HCl [pH 7.4], 1% [w/v] TX-100),
tic acid (typically 40±60 Ci/mmol and 1 mCi/ml, Amersham Life Sci-
and adjusted to 5 mM potassium phosphate (pH 7.4). This was
ence, UK).
loaded on a 5 ml Biogel-HTP column equilibrated with HTP5 (25 mM
Tris±HCl [pH 7.4], 100 mM KCl, 1% [w/v] TX-100, 5 mM potassium
phosphate). After washing with 10 ml of HTP5, the column was Immunoprecipitations
Immunoprecipitations were performed in IP buffer (20 mM HEPES±eluted with a 20 ml linear gradient of HTP5 to HTP200 (25 mM
Tris±HCl [pH 7.4], 100 mM KCl, 1% [w/v] TX-100, 200 mM potassium KOH [pH 7.3], 200 mM KCl, 0.5 % [w/v] TX-100) using 5 ml of the
appropriate antiserum and either 10 ml of packed protein A- orphosphate) collecting 1 ml fractions. At this step p65 was separated
from p130, and they eluted with peaks at 75 mM and 125 mM protein G-Sepharose (Pharmacia) for rabbit polyclonal and mouse
monoclonal antibodies, respectively. After binding for 60 minutesphosphate, respectively. Peak fractions of p65 were pooled (3 ml)
and diluted to 15 ml in Q0 prior to loading on a 1 ml Q-Sepharose at 48C, the beads were washed four times with 500 ml of IP buffer
and eluted with 30 ml of SDS±PAGE sample buffer, and the eluatecolumn equilibrated in Q100. After washing with 10 ml of Q100, the
column was eluted with a 20 ml linear gradient of Q100 to Q1000, was analyzed as appropriate.
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Immunofluorescence Microscopy Golgi, C. (1898). Sur la structure des cellules nerveuses. Archives
Italiennes de Biologie 30, 60±71.NRK or Hela cells grown on glass coverslips were fixed for 4 minutes
in methanol at 2208C, then washed three times in PBS. All antibody Johnson, D.R., Bhatnagar, R.S., Knoll, L.J., and Gordon, J.I. (1994).
labelings were for 20 minutes in PBS. For double-labeling, rabbit Genetic and biochemical studies of protein N-myristoylation. Annu.
polyclonals were detected with rhodamine-conjugated anti-rabbit, Rev. Biochem. 63, 869±914.
and monoclonals with fluorescein-conjugated anti-mouse anti- Liu, J., Garcia Cardena, G., and Sessa, W.C. (1996). Palmitoylation of
bodies. endothelial nitric oxide synthase is necessary for optimal stimulated
release of nitric oxide: implications for caveolae localization. Bio-
Transient Tranfections chemistry 35, 13277±13281.
Constructs for transient transfections were in pcDNA3.11 (In- Meffert, M.K., Calakos, N.C., Scheller, R.H., and Schulman, H. (1996).
vitrogen). Hela cells were plated at 10% density in 2-cm wells con- Nitric oxide modulates synaptic vesicle docking fusion reactions.
taining a glass coverslip and left to attach for 12 hours. Transfection Neuron 16, 1229±1236.
of 2.5 mg of plasmid DNA per well was performed using the calcium
Misteli, T., and Warren, G. (1994). COP-coated vesicles are involvedphosphate precipitation method (Nilsson etal., 1993). After 24 hours,
in the mitotic fragmentation of Golgi stacks in a cell-free system. J.cells were fixed and processed for immunofluorescence with appro-
Cell. Biol. 125, 269±282.priate antibodies.
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